TABLE 3.
Transcript ID | Position | Gene | Number of variants | P value | Corrected P value |
NM_001397 | chr1:21543823.21671981 | ECE1 | 70 | 0.3996 | 0.1528 |
NM_033467 | chr1:2522081.2564481 | MMEL1 | 56 | 0.5486 | 0.3231 |
NM_001286126 | chr1:220701525.220837799 | MARK1 | 46 | 0.2011 | 0.2113 |
NM_139343 | chr2:127805599.127864903 | BIN1 | 54 | 0.0865 | 0.2066 |
NM_002093 | chr3:119540800.119813264 | GSK3B | 70 | 0.8488 | 0.8357 |
NM_000902 | chr3:154797436.154901518 | NEP | 60 | 0.0035 | 0.0232 |
NM_002715 | chr5:133532148.133561950 | PPP2CA | 7 | 0.2398 | 0.2946 |
NM_004935 | chr7:150750899.150755052 | CDK5 | 15 | 0.8119 | 1 |
NM_002717 | chr8:26149007.26230196 | PPP2R2A | 27 | 0.3782 | 0.2614 |
NM_001322795 | chr10:94211441.94333852 | IDE | 55 | 0.2392 | 0.0729 |
NM_016147 | chr11:73882108.73965748 | PPME1 | 22 | 0.03766 | 0.2638 |
NM_012104 | chr11:117156402.117186972 | BACE1 | 18 | 0.4485 | 0.3147 |
NM_001134999 | chr14:53323989.53417815 | FERMT2 | 28 | 0.0192 | 0.0159 |
NM_006305 | chr15:69070874.69113261 | ANP32A | 23 | 1 | 0.7828 |
NM_001032391 | chr16:25123047.25189551 | LCMT1 | 19 | 0.8202 | 0.9217 |
NM_000789 | chr17:61554422.61575741 | ACE | 85 | 0.2817 | 0.2429 |
NM_006221 | chr19:9945883.9960365 | PIN1 | 15 | 0.2137 | 0.3725 |
NM_004994 | chr20:44637547.44645200 | MMP9 | 25 | 0.2139 | 0.3106 |
NM_138991 | chr21:42539728.42654461 | BACE2 | 84 | 0.2815 | 0.1322 |
P value, P value before correction; Corrected P-value, P-value after the adjustment of age, gender, and APOEε4 status; SKAT-O, optimized sequence kernel association test.
Corrected P-value < 0.0026 (0.05/19) was considered as statistically significant.